@misc{indiciae0e14e53f5523,
  title = {A Seamless Phase I/II Platform Design with a Time-To-Event Efficacy Endpoint for Potential COVID-19 Therapies},
  author = {Thomas Jaki and Helen Barnett and Andrew Titman and Pavel Mozgunov},
  year = {2020},
  url = {https://arxiv.org/abs/2010.06518},
  note = {Source identifier: 2010.06518}
}